Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jove

Showing results (491-500 of 517) with videos related to

Pageof 52
Sort By:
Cancer|February 23, 2022
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancerLuis Paz-Ares, David R Spigel, Yuanbin Chen, et al.
Cancer Research|July 23, 2014
TLR9 is critical for glioma stem cell maintenance and targetingAndreas Herrmann, Gregory Cherryholmes, Anne Schroeder, et al.
The New Zealand Medical Journal|July 28, 2023
PATHA's vision for transgender healthcare under the current health reformsJaimie F Veale, Jemima J Bullock, Jack Byrne, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 29, 2020
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)J Valero, P Peleteiro, I Henríquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2024
Reply to P. de Boissieu et alDavid R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung CancerDavid R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Stem Cells Translational Medicine|November 8, 2018
Regenerative Medicine in the State of Florida: Letter Outlining the Florida Organization for Regenerative MedicineCharles J Bruce, Guojun Bu, John M Centanni, et al.
The Journal of Investigative Dermatology|June 24, 2011
Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancerWynn H Kao, Adam I Riker, Deepa S Kushwaha, et al.
Cancer Research|December 17, 2008
The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?Joelle Hillion, Surajit Dhara, Takita Felder Sumter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cellsTanya Gritsko, Ann Williams, James Turkson, et al.
Pageof 52

Showing results (491-500 of 517) with videos related to

Sort By:
Pageof 52
Cancer|February 23, 2022
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancerLuis Paz-Ares, David R Spigel, Yuanbin Chen, et al.
Cancer Research|July 23, 2014
TLR9 is critical for glioma stem cell maintenance and targetingAndreas Herrmann, Gregory Cherryholmes, Anne Schroeder, et al.
The New Zealand Medical Journal|July 28, 2023
PATHA's vision for transgender healthcare under the current health reformsJaimie F Veale, Jemima J Bullock, Jack Byrne, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 29, 2020
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)J Valero, P Peleteiro, I Henríquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2024
Reply to P. de Boissieu et alDavid R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung CancerDavid R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Stem Cells Translational Medicine|November 8, 2018
Regenerative Medicine in the State of Florida: Letter Outlining the Florida Organization for Regenerative MedicineCharles J Bruce, Guojun Bu, John M Centanni, et al.
The Journal of Investigative Dermatology|June 24, 2011
Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancerWynn H Kao, Adam I Riker, Deepa S Kushwaha, et al.
Cancer Research|December 17, 2008
The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?Joelle Hillion, Surajit Dhara, Takita Felder Sumter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cellsTanya Gritsko, Ann Williams, James Turkson, et al.
Pageof 52